Timothy Mitchell
Founder bei SAREUM HOLDINGS PLC
Vermögen: 140 222 $ am 31.03.2024
Profil
Timothy John Mitchell was the founder of Sareum Holdings Plc, where he held the title of Chief Executive Officer & Executive Director until his departure.
Sareum Holdings Plc was founded in 2003.
Dr. Mitchell's former positions include Director-Computational Chemistry at Cambridge Discovery Chemistry and Director-Structure Based Discovery at Millennium Pharmaceuticals Research & Development Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SAREUM HOLDINGS PLC
1,44% | 28.03.2024 | 1 032 561 ( 1,44% ) | 140 222 $ | 31.03.2024 |
Aktive Positionen von Timothy Mitchell
| Unternehmen | Position | Beginn |
|---|---|---|
| SAREUM HOLDINGS PLC | Founder | 01.08.2003 |
Ehemalige bekannte Positionen von Timothy Mitchell
| Unternehmen | Position | Ende |
|---|---|---|
| Millennium Pharmaceuticals Research & Development Ltd. | Corporate Officer/Principal | - |
Cambridge Discovery Chemistry
 Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAREUM HOLDINGS PLC | Miscellaneous |
| Private Unternehmen | 2 |
|---|---|
Cambridge Discovery Chemistry
Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Commercial Services |
| Millennium Pharmaceuticals Research & Development Ltd. |
